Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 2
2016 6
2017 3
2018 3
2019 1
2020 2
2023 1
2024 1
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Lymphodepleting preconditioning impairs host antitumor immunity induced by adoptive T cell therapy in mouse models.
Figueroa D, Vega JP, Hernández-Oliveras A, Ardiles F, Hidalgo S, López X, Saavedra V, Bustamante C, Malavé D, Flores F, Gálvez-Cancino F, Gonzalez H, Varas-Godoy M, Bono MR, Osorio F, Borgna V, Lladser A. Figueroa D, et al. Among authors: borgna v. Nat Commun. 2026 Mar 31;17(1):4337. doi: 10.1038/s41467-026-71082-y. Nat Commun. 2026. PMID: 41912536 Free PMC article.
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Morgado-Cáceres P, Hofmann-Vega F, Figueroa D, Saavedra-Almarza J, Gálvez-Cancino F, Díaz X, Menares E, Roa E, Hidalgo S, Varas-Godoy M, Borgna V, Lladser A. Morgado-Cáceres P, et al. Among authors: borgna v. Oncoimmunology. 2026 Dec 31;15(1):2606497. doi: 10.1080/2162402X.2025.2606497. Epub 2026 Jan 11. Oncoimmunology. 2026. PMID: 41521424 Free PMC article.
Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer.
Lopez E, Hidalgo S, Roa E, Gómez J, Hermansen Truan C, Sanders E, Carrasco C, Pacheco R, Salazar-Onfray F, Varas-Godoy M, Borgna V, Lladser A. Lopez E, et al. Among authors: borgna v. Oncoimmunology. 2023 Jun 22;12(1):2225291. doi: 10.1080/2162402X.2023.2225291. eCollection 2023. Oncoimmunology. 2023. PMID: 37363103 Free PMC article.
Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors.
Borgna V, Lobos-González L, Guevara F, Landerer E, Bendek M, Ávila R, Silva V, Villota C, Araya M, Rivas A, López C, Socias T, Castillo J, Alarcón L, Burzio LO, Burzio VA, Villegas J. Borgna V, et al. J Cancer. 2020 Jan 17;11(7):1780-1791. doi: 10.7150/jca.38880. eCollection 2020. J Cancer. 2020. PMID: 32194789 Free PMC article.
Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors.
Fitzpatrick C, Bendek MF, Briones M, Farfán N, Silva VA, Nardocci G, Montecino M, Boland A, Deleuze JF, Villegas J, Villota C, Silva V, Lobos-Gonzalez L, Borgna V, Barrey E, Burzio LO, Burzio VA. Fitzpatrick C, et al. Among authors: borgna v. Cell Death Dis. 2019 May 29;10(6):423. doi: 10.1038/s41419-019-1649-3. Cell Death Dis. 2019. PMID: 31142736 Free PMC article.
Vaccination-induced skin-resident memory CD8+ T cells mediate strong protection against cutaneous melanoma.
Gálvez-Cancino F, López E, Menares E, Díaz X, Flores C, Cáceres P, Hidalgo S, Chovar O, Alcántara-Hernández M, Borgna V, Varas-Godoy M, Salazar-Onfray F, Idoyaga J, Lladser A. Gálvez-Cancino F, et al. Among authors: borgna v. Oncoimmunology. 2018 Mar 19;7(7):e1442163. doi: 10.1080/2162402X.2018.1442163. eCollection 2018. Oncoimmunology. 2018. PMID: 29900048 Free PMC article.
21 results